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To the Editor: In 1994, dengue
virus type 3 (DENV-3) was reintro-
duced into Latin America after an
absence of 17 years, and was isolated
almost simultaneously in Nicaragua
and Panama. In September 2000,
DENV-3 was isolated for the first
time in Cuba, producing a small out-
break that affected 3 areas of Havana
City. In total, 138 cases of dengue
fever were confirmed, with either
DENV-3 or DENV-4 as the etiologic
agents. No dengue hemorrhagic fever
cases were observed, and the outbreak
was brought under control within 6
weeks (1). At the end of June 2001,
dengue was again reported in Havana.
Through the end of February 2002, a
total of 14,443 dengue cases were
reported for the entire country, includ-
ing 81 cases of dengue hemorrhagic
fever and 3 fatalities (2).
To understand the molecular epi-
demiology of DENV-3 in Cuba, and
particularly to determine whether the
2000 and 2001 outbreaks were caused
by the same viral genotype, the com-
plete envelope (E) gene sequences of
isolates from both outbreaks were
determined. To assist in this analysis,
we also sequenced a DENV-3 strain
representing the 1994 Nicaraguan epi-
demic, the first one isolated in Latin
America in 1994 (3).
Three DENV-3 viruses isolated
during the 2000–2002 Cuban out-
breaks were studied. Two were
obtained from acute-phase sera and
the other from a spleen section sample
from a patient who died. Serum sam-
ples and macerated spleen fragments
were spread onto C6/36 mosquito
cells (grown at 33°C) by using the
rapid centrifugation assay (4).
Viral RNAwas extracted from 200
µL of supernatant medium of virus-
infected cells by using the RNAgents
Total RNA Isolation system
(Promega, Madison, WI, USA). The E
gene was amplified by using reverse
transcription–polymerase chain reac-
tion (RT-PCR) as described previous-
ly (5). Double-stranded sequencing of
the E gene was conducted on an ABI
sequencer according to the manufac-
ture’s protocol (Applied Biosystems,
Foster City, CA, USA). All sequences
determined in this study have been
deposited in GenBank (accession nos.
AY702030–AY702033).
The E gene sequence of the 3
Cuban DENV-3 isolates and the sin-
gle strain from Nicaragua isolated in
1994 were aligned with the E gene
sequences (1,479 bp in length) of 60
DENV-3 isolates deposited in
GenBank, representing the global
genetic diversity of DENV-3.
Phylogenetic trees were produced
with a maximum likelihood method
incorporating the GTR+ Γ+I model of
nucleotide substitution, with the gen-
eral time-reversible (GTR) substitu-
tion matrix, the base composition, the
gamma (Γ) distribution of among-site
rate variation, and the proportion of
invariant sites (I) all estimated from
the data. To explore the robustness of
particular phylogenetic groupings, a
bootstrap resampling analysis was
undertaken. All analyses were per-
formed with the PAUP* package (6).
The tree (Figure) showed 5 major
groups or genotypes of DENV-3: 1) a
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 5, May 2005 773
Figure. Maximum likelihood (ML) phylogenetic tree showing the evolutionary relationships
among the E gene sequences of 64 strains of DENV-3. All branch lengths are drawn to
scale, and tree was rooted using strains from the Puerto Rico 1960s epidemic, which
always appear as the most divergent. Bootstrap support values are shown for key nodes
only; the Cuban isolates are designated by bold type. See online Appendix Table (avail-
able at http://www.cdc.gov/ncidod/eid/vol11no05/04-0916_app.htm) for GenBank acces-
sion numbers of the other DENV-3 strains used in this analysis.LETTERS
Pacific/Asian group (genotype I); 2)
an Asian group, containing a large
array of viruses sampled from
Thailand and Malaysia (genotype II);
3) a Latin American group that
includes the Cuban viruses and iso-
lates from Venezuela, Martinique, and
Nicaragua, as well as those from
Samoa, India, and Sri Lanka (genotype
III); 4) a small group of Asian viruses
(genotype IV); and 5) a final, most
divergent group containing virus sam-
ples from Puerto Rico (genotype V). A
similar genotype structure of DENV-3
has been observed in previous studies
of this virus (5, 7–9). The 3 Cuban
viruses clearly fall into genotype III.
Indeed, strain D3.Nicaragua.24/94
falls at the base of the Latin American
clade within genotype III, as would be
expected if it was the first DENV-3
strain isolated from this region in
1994. Moreover, the most divergent
strains from genotype III (with the
exception of a single strain from
Samoa) come from Asia, which sug-
gests that this group of viruses was
exported from Asia to Latin America
in the early 1990s. Finally, the Cuban
viruses fall into 2 distinct groups: the
116/00 strain, isolated during the
2000 outbreak, is very closely related
to the Brazilian/Martinique viruses
isolated in the same year, whereas
strains 580/01 and 21/02, isolated in
2001–2002, appear to have diverged
distinctly to form a separate cluster
(99% bootstrap support).
Atotal of 15 nucleotide differences
were distributed throughout the E
gene. Of these, 12 were synonymous
and 3 were nonsynonymous substitu-
tions resulting in amino acid changes
(E19 Thr/Pro, E226 Ile/Thr, and E329
Ala/Val). Moreover, 2 different
nucleotide substitutions were found
for the 2 isolates obtained during the
major outbreak (2001–2002). These
substitutions resulted in a nonconser-
vative amino acid change (E22
Asp/Val). The ABI chromatograms of
these sequences showed populations
in this position, but the predominant
population for each strain differed.
By using appropriate phylogenetic
methods, deducing the most likely
dispersal pattern for closely related
dengue virus strains with different
patterns of spatial and temporal sam-
pling is possible. The current study
strongly suggests that an Asian
DENV-3 virus assigned to genotype
III has evolved in situ in the
Caribbean region since 1994.
The nucleotide differences
observed in the Cuban isolates sup-
port the hypothesis that DENV-3 was
introduced twice into Cuba from the
wider Latin American region. Further
evidence to support this hypothesis is
that during the interepidemic period,
from January to June 2001, no
immunoglobulin (Ig) M–positive
samples from patients with fever and
suspected dengue cases were
observed, which suggests that the
virus was not circulating. Therefore,
these data are consistent with the idea
that, rather than in situ evolution, a
second introduction of the virus
occurred in 2001.
By comparing the amino acid
sequences of the Cuban isolates with
other DENV-3 strains assigned to
genotype III, we confirmed that sever-
al distinct amino acid replacements
had occurred. In particular, the non-
conservative substitution Ala/Val was
seen in the Nicaragua 1994, Mexico
1996, Cuba 2001–2002, and Vene-
zuela 2001–2002 isolates. However,
the Cuba 2000, Brazil 2000, and
Martinique 1999–2001 isolates pre-
served the Ala at this position, as was
also the case for viruses sampled from
the putative Asian source (from India
and Sri Lanka). The functional signif-
icance of amino acids at this position
has not been determined.
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